Tag:
QuatRx Pharmaceuticals
Latest Headlines
Latest Headlines
QuatRx gains $125M licensing pact
QuatRx has scored a $125 million licensing deal with Shionogi. The Japanese company will pay $25 million of that upfront for the worldwide marketing rights to ospemifene for the treatment of
